| 0 |
SUBCONJUNCTIVAL FIBROSIS |
1 |
0.0909 |
| 1 |
BLASTOCYSTIS INFECTION |
1 |
0.0115 |
| 2 |
CERVIX CANCER METASTATIC |
1 |
0.0061 |
| 3 |
PORTAL FIBROSIS |
1 |
0.0047 |
| 4 |
SYMBLEPHARON |
1 |
0.0038 |
| 5 |
EYE INFECTION STAPHYLOCOCCAL |
1 |
0.0035 |
| 6 |
THYROID HORMONES DECREASED |
1 |
0.0013 |
| 7 |
CSF PROTEIN INCREASED |
1 |
0.0012 |
| 8 |
ANTINUCLEAR ANTIBODY INCREASED |
1 |
0.0010 |
| 9 |
TESTICULAR DISORDER |
1 |
0.0010 |
| 10 |
BLOOD TESTOSTERONE INCREASED |
2 |
0.0009 |
| 11 |
SEROMA |
1 |
0.0008 |
| 12 |
COSTOCHONDRITIS |
1 |
0.0006 |
| 13 |
PRODUCT COUNTERFEIT |
1 |
0.0006 |
| 14 |
EARLY SATIETY |
1 |
0.0005 |
| 15 |
CLOSTRIDIUM TEST POSITIVE |
1 |
0.0005 |
| 16 |
BLOOD IMMUNOGLOBULIN E INCREASED |
1 |
0.0004 |
| 17 |
CANCER PAIN |
1 |
0.0004 |
| 18 |
CLUMSINESS |
1 |
0.0004 |
| 19 |
MIXED LIVER INJURY |
1 |
0.0003 |
| 20 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0003 |
| 21 |
HAEMORRHAGIC DIATHESIS |
1 |
0.0003 |
| 22 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 23 |
OCULAR ICTERUS |
1 |
0.0002 |
| 24 |
URINE ABNORMALITY |
1 |
0.0002 |
| 25 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
3 |
0.0002 |
| 26 |
STOMACH DISCOMFORT |
1 |
0.0002 |
| 27 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 28 |
SWELLING OF EYELID |
1 |
0.0002 |
| 29 |
DYSGRAPHIA |
1 |
0.0002 |
| 30 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 31 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 32 |
CARDIAC MURMUR |
1 |
0.0001 |
| 33 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 34 |
HELICOBACTER INFECTION |
1 |
0.0001 |
| 35 |
URINARY RETENTION |
3 |
0.0001 |
| 36 |
CHROMATURIA |
2 |
0.0001 |
| 37 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 38 |
SOPOR |
1 |
0.0001 |
| 39 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 40 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 41 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 42 |
HAEMATURIA |
2 |
0.0001 |
| 43 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 44 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 45 |
HERNIA |
1 |
0.0001 |
| 46 |
SKIN FISSURES |
1 |
0.0001 |
| 47 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 48 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 49 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 50 |
ORAL PAIN |
1 |
0.0000 |
| 51 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 52 |
LIVER INJURY |
1 |
0.0000 |
| 53 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 54 |
HAEMATEMESIS |
1 |
0.0000 |
| 55 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 56 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 57 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 58 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 59 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 60 |
CHOLELITHIASIS |
1 |
0.0000 |
| 61 |
SLEEP DISORDER |
2 |
0.0000 |
| 62 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 63 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 64 |
COLITIS |
1 |
0.0000 |
| 65 |
DYSKINESIA |
1 |
0.0000 |
| 66 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 67 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 68 |
AGGRESSION |
1 |
0.0000 |
| 69 |
FLUID RETENTION |
1 |
0.0000 |
| 70 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 71 |
INFLAMMATION |
1 |
0.0000 |
| 72 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 73 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 74 |
SPEECH DISORDER |
1 |
0.0000 |
| 75 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 76 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 77 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 78 |
HERPES ZOSTER |
1 |
0.0000 |
| 79 |
NASAL CONGESTION |
1 |
0.0000 |
| 80 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 81 |
STOMATITIS |
1 |
0.0000 |
| 82 |
DISCOMFORT |
1 |
0.0000 |
| 83 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 84 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 85 |
RHINORRHOEA |
1 |
0.0000 |
| 86 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 87 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 88 |
BURNING SENSATION |
1 |
0.0000 |
| 89 |
AGITATION |
1 |
0.0000 |
| 90 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 91 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 92 |
DECREASED APPETITE |
3 |
0.0000 |
| 93 |
BACK PAIN |
3 |
0.0000 |
| 94 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 95 |
DRUG INTERACTION |
2 |
0.0000 |
| 96 |
TREATMENT FAILURE |
1 |
0.0000 |
| 97 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 98 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 99 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 100 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 101 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 102 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 103 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 104 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 105 |
BREAST CANCER |
1 |
0.0000 |
| 106 |
SWELLING |
1 |
0.0000 |
| 107 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 108 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 109 |
SOMNOLENCE |
2 |
0.0000 |
| 110 |
ILLNESS |
1 |
0.0000 |
| 111 |
RASH |
4 |
0.0000 |
| 112 |
CONSTIPATION |
2 |
0.0000 |
| 113 |
INFLUENZA |
1 |
0.0000 |
| 114 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 115 |
PYREXIA |
3 |
0.0000 |
| 116 |
VOMITING |
4 |
0.0000 |
| 117 |
JOINT SWELLING |
1 |
0.0000 |
| 118 |
DEHYDRATION |
1 |
0.0000 |
| 119 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 120 |
VISION BLURRED |
1 |
0.0000 |
| 121 |
INFECTION |
1 |
0.0000 |
| 122 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 123 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 124 |
PAIN |
4 |
0.0000 |
| 125 |
FATIGUE |
5 |
0.0000 |
| 126 |
COVID-19 |
1 |
0.0000 |
| 127 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 128 |
MUSCLE SPASMS |
1 |
0.0000 |
| 129 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 130 |
ALOPECIA |
1 |
0.0000 |
| 131 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 132 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 133 |
HYPERTENSION |
1 |
0.0000 |
| 134 |
DIARRHOEA |
3 |
0.0000 |
| 135 |
WEIGHT INCREASED |
1 |
0.0000 |
| 136 |
DEPRESSION |
1 |
0.0000 |
| 137 |
FEELING ABNORMAL |
1 |
0.0000 |
| 138 |
INSOMNIA |
1 |
0.0000 |
| 139 |
WEIGHT DECREASED |
1 |
0.0000 |
| 140 |
HEADACHE |
2 |
0.0000 |
| 141 |
ASTHENIA |
1 |
0.0000 |
| 142 |
PRURITUS |
1 |
0.0000 |
| 143 |
NAUSEA |
2 |
0.0000 |
| 144 |
ARTHRALGIA |
1 |
0.0000 |
| 145 |
OFF LABEL USE |
2 |
0.0000 |
| 146 |
MALAISE |
1 |
0.0000 |
| 147 |
DRUG INEFFECTIVE |
3 |
0.0000 |
| 148 |
DIZZINESS |
1 |
0.0000 |